Statistical aspect of translational and correlative studies in clinical trials.

about

Statistical aspect of translational and correlative studies in clinical trials.

Item

http://www.wikidata.org/entity/Q36658054

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statistical aspect of translational and correlative studies in clinical trials.

@ast

Statistical aspect of translational and correlative studies in clinical trials.

@en

type

Item

label

Statistical aspect of translational and correlative studies in clinical trials.

@ast

Statistical aspect of translational and correlative studies in clinical trials.

@en

prefLabel

Statistical aspect of translational and correlative studies in clinical trials.

@ast

Statistical aspect of translational and correlative studies in clinical trials.

@en

P1476

Statistical aspect of translational and correlative studies in clinical trials.

@en

P2093

Herbert Pang

http://www.w3.org/2001/XMLSchema#string

Xiaofei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.

Time-dependent ROC curves for censored survival data and a diagnostic marker.

Sample size for FDR-control in microarray data analysis.

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sample size planning for developing classifiers using high-dimensional DNA microarray data.

Pathway analysis using random forests with bivariate node-split for survival outcomes

Evaluating the yield of medical tests.

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2304-3865.2014.07.04

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26932435

http://www.w3.org/2001/XMLSchema#string

P932

4780353

http://www.w3.org/2001/XMLSchema#string